Paradigm Capital Management Inc. NY Invests $5.31 Million in Addus HomeCare Corporation $ADUS

Paradigm Capital Management Inc. NY acquired a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) during the second quarter, HoldingsChannel reports. The institutional investor acquired 52,870 shares of the company’s stock, valued at approximately $5,312,000.

A number of other large investors have also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund grew its position in Addus HomeCare by 2.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after purchasing an additional 103 shares during the last quarter. ProShare Advisors LLC boosted its holdings in Addus HomeCare by 3.1% during the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock worth $379,000 after buying an additional 105 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in Addus HomeCare by 0.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after acquiring an additional 106 shares in the last quarter. State of Wyoming lifted its position in shares of Addus HomeCare by 25.7% in the fourth quarter. State of Wyoming now owns 523 shares of the company’s stock valued at $56,000 after acquiring an additional 107 shares in the last quarter. Finally, Pathstone Holdings LLC boosted its stake in shares of Addus HomeCare by 0.9% during the 3rd quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock worth $1,502,000 after purchasing an additional 112 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $120.82 on Tuesday. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The stock has a market cap of $2.26 billion, a PE ratio of 21.20, a price-to-earnings-growth ratio of 1.62 and a beta of 0.87. The company’s 50-day moving average price is $109.99 and its two-hundred day moving average price is $102.58. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.03. The firm had revenue of $377.41 million for the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.49 earnings per share. As a group, sell-side analysts anticipate that Addus HomeCare Corporation will post 6.29 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several recent analyst reports. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Royal Bank Of Canada raised their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Finally, Barclays boosted their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $130.88.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.